Sort   by:  
 Page size 
UnknownChanges in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort.
Not available
S-EPMC10322216 | biostudies-literature
UnknownMeiotic onset is reliant on spatial distribution but independent of germ cell number in the mouse ovary.
Not available
S-EPMC5930833 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownLIF signaling regulates outer radial glial to interneuron fate during human cortical development.
Not available
S-EPMC10591955 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownDomains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.
Not available
S-EPMC12067843 | biostudies-literature
UnknownTropism of SARS-CoV-2 for human cortical astrocytes.
Not available
S-EPMC9335272 | biostudies-literature
UnknownA single-cell atlas of the normal and malformed human brain vasculature.
Not available
S-EPMC8995178 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownTrial of Solanezumab in Preclinical Alzheimer's Disease.
Not available
S-EPMC10559996 | biostudies-literature
Sort   by:  
 Page size